Cognito Therapeutics Ltd. announced it raised $53.3 Million in an initial filing from an offering of $126 Million

Company

Location

About

Cognito Therapeutics is a pioneer in non-invasive neuromodulation to treat neurodegenerative diseases and improve human cognitive performance. The company has completed multiple clinical studies demonstrating its investigational therapeutic has the potential to safely slow or stop cognitive decline and loss of brain volume in Alzheimer’s disease.